Enveric Biosciences Inc. (ENVB): Price and Financial Metrics
ENVB Price/Volume Stats
| Current price | $1.31 | 52-week high | $11.82 |
| Prev. close | $1.26 | 52-week low | $1.01 |
| Day low | $1.26 | Volume | 64,558 |
| Day high | $1.33 | Avg. volume | 1,720,140 |
| 50-day MA | $1.28 | Dividend yield | N/A |
| 200-day MA | $4.20 | Market Cap | 3.23M |
ENVB Stock Price Chart Interactive Chart >
Enveric Biosciences Inc. (ENVB) Company Bio
Enveric Biosciences Inc., formerly AMERI Holdings, Inc., is a patient-central biotechnology company. The Company is focused on enhancing lives of people affected by the side effects of cancer treatments, such as radiodermatitis and chemotherapy-induced peripheral neuropathy. The Company is engaged in leveraging its clinical developments derived from ... More
ENVB Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ENVB Price Returns
| 1-mo | 8.26% |
| 3-mo | -28.02% |
| 6-mo | -73.30% |
| 1-year | -88.58% |
| 3-year | -99.20% |
| 5-year | -99.98% |
| YTD | -75.63% |
| 2024 | -72.43% |
| 2023 | -37.50% |
| 2022 | -95.53% |
| 2021 | -78.17% |
| 2020 | N/A |